Rising incidence of sport related injuries are driving the market growth. Awareness among athletes to maintain their fitness levels has been a factor in promoting the growth of the sport medicine market in Asia Pacific. These factors increase the demand for devices such as bone graft substitutes, surgical devices, and arthroscopy devices.
The sports medicine market in the Asia-Pacific region is leading in China, India, Japan, and South Korea.
Based on geography, the APAC Sports Medicine market is segmented into 11 geographical regions, such as,
Rest of APAC.
APAC Sports Medicine market competition by top players including -
Arthrex, Inc. is going to dominate the APAC sports medicine market following with Smith & Nephew and DePuy Synthes, along with others such as
Johnson & Johnson,
Bird & Cronin, Inc.,
Ossur, Breg Inc.,
Mueller Sports Medicine, Inc.,
The APAC sports medicine market is segmented on the basis of product type, body area, procedures, end user, and geography.
On the basis of product type, the APAC sports medicine market is segmented into 4 types, such as arthroscopy devices, orthobiologics, surgical devices, orthopedic braces and supports. In 2017, surgical devices market segment is projected to account for the largest share of 47.9% of the APAC sports medicine market.
On the basis of body area, APAC sports medicine market is segmented into hip, shoulder & elbow, knee, foot & ankle and wrist & hand on the basis of body area.
On the basis of procedures, APAC sports medicine market is segmented into, hip arthroscopic procedures, knee arthroscopic procedures, shoulder and elbow arthroscopic procedures, , and hand and wrist arthroscopic procedures. foot and ankle arthroscopic procedures. Knee arthroscopic procedure market segment is expected to account for the largest share of 40.6% in APAC sports medicine market.
On the basis of end users, the market is classified into, hospitals, orthopedic clinics, ambulatory surgical centers and others. In 2017, the hospitals segment is expected to dominate the APAC sports medicine market with 56.0% market share. This segment is expected to grow at the highest CAGR of 13.7% in the forecast period 2017 to 2024.